Shares Of Biogen Jump 7% After Hours on Increased Sales Of Multiple Sclerosis Drug

Biogen Idec (BIIB) is a biotechnology company that has a focus on treatments for Multiple Sclerosis and Hemophilia. Shares of Biogen are up 7% after hours after the company reported positive earnings beating out analysts expectations. Biogen’s net income in… Continue Reading


Cellceutix Surged As Much As 17% After Lesion Clearance In Metastatic Cancer

Shares of Cellceutix (CTIX) soared as much as 17% on Jan 20, 2015 after the company announced the results from its phase 1 cancer trial with Kevetrin. The company reported that a patient in the phase 1 clinical trial was… Continue Reading


Cytrx Corporation Announces That The FDA Has Removed The Partial Clinical Hold For Its Cancer Drug

Cytrx Corporation (CYTR) is a biotechnology stock focused primarily on creating new forms of treatments for cancer patients. Shares of Cytrx Corporation surged as high as 10% pre-market on the news that the FDA has lifted the partial clinical hold… Continue Reading


Tekmira Pharmaceuticals Shares Soar 57% After Merger Agreement With OnCore Biopharma

Shares of Tekmira Pharmaceuticals (TKMR) soared as much as 57% on Monday Jan. 12, 2015 after the company reported that it had entered into a merger agreement with Oncore Biopharma. Tekmira is a biotechnology company focused on developing RNAi therapeutics… Continue Reading


Cytrx Reports Positive Phase 2 Results In Patients With Brain Cancer Using Aldoxorubicin

Shares of Cytrx Corporation (CYTR) soared 20% on the news that their cancer drug, Aldoxorubicin, achieved positive phase 2 results in patients with brain cancer. Phase 2 is to show clinical efficacy but Cytrx hit the ball out of the… Continue Reading


Shares of Arrowhead Surge As Much As 25% After Gilead Buyout Rumors

Shares of Arrowhead Research Corp. (ARWR) surged as much as 25% in today’s trading session after rumors circulated that Gilead Sciences (GILD) may have an interest in acquiring the RNAi biotechnology company. Arrowhead is working on creating a potential drug… Continue Reading


Vanda Surges After Novartis Agrees To Settle Dispute Over Schizophrenia Drug

Shares of Vanda Pharmaceuticals (VNDA) surged as much as 15% in today’s session as Novartis (NVS) has agreed to give back the rights of Fanapt, a schizophrenia drug, back to the company. Novartis had high hopes when it first acquired… Continue Reading


Arrowhead Announces IND Filing To Begin Two Trials For Hepatitis B

Shares of Arrowhead Research Corp (ARWR) jumped 10% today on the news that the company has filed an IND to the FDA to begin testing two phase 2b trials using its drug ARC-520 in patients with the Hepatitis B virus.… Continue Reading


Shares of Bluebird Bio Surge 60% At Market Open On Positive Results Against Rare Blood Disease

Shares of Bluebird Bio (BLUE) jumped  60% on the open after it had announced that one if its drugs Lentiglobin BB305 which utilizes gene therapy was able to allow patients to become tranfusion free. Bluebird Bio is a biotechnology stock… Continue Reading


IsoRay’s Drug Stops Brain Cancer From Recurring In Advanced Stage Cancer patients

Yesterday December 1, 2014 Isoray (ISR) reported positive results in a brain cancer study where the patients’ recurrence of brain cancer was completely stopped . The patients were treated with Isoray’s drug known as Cesium-131 which is a titanium radioactive… Continue Reading